RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Myriad Genetics Incorporated

A collection of news and information related to Myriad Genetics Incorporated published by this site and its partners.

Top Myriad Genetics Incorporated Articles see all

Displaying items 1-5
  • 23andMe's designer baby patent is 'a serious mistake,' critics charge

    23andMe's designer baby patent is 'a serious mistake,' critics charge
    What’s even more repulsive than the idea of using DNA tests to help people create a designer babies? Getting a patent for the idea.
  • Diversified media giant weathering defections to ride strong financial standing

    About Discovery Communications Inc. Ticker: DISCA Exchange: Nasdaq What does the company do? Media and entertainment company 2010 Financial report: Total revenues: $3.77 billion Net income: $653 million Q. Please advise me on my shares of Discovery...

    Dr. Bernardo Fernandez, president, Cleveland Clinic Florida

    Dr. Bernardo Fernandez, president, Cleveland Clinic Florida
    Last week: Dolphins, your wins mean a lot more than you may think. A recent article by Pierre Chandon in Forbes Magazine brought to light how much we need our sports teams to win ... for our health. The article cites a study by Cornil and Chandon that...

    Gene patent case could impact patients, research

    Gene patent case could impact patients, research
    Every time a woman is tested for gene mutations linked to significantly higher rates of breast and ovarian cancer, her blood is sent to a lab in Utah. That's because Salt Lake City-based Myriad Genetics Inc. owns the patents to the BRCA 1 and BRCA 2...

    Researchers hail Supreme Court decision on gene patent

    Researchers hail Supreme Court decision on gene patent
    The U.S. Supreme Court decision that Myriad Genetics cannot patent two genes linked to ovarian and breast cancer came as welcome relief to researchers whose work on BRCA1 and BRCA2 genes had been thwarted by legal challenges from the company. But...